Global Anti-thrombin III Testing Market Growth (Status and Outlook) 2025-2031

September 2025 | 80 pages | ID: G00A67545682EN
LP Information

Abstracts

According to this study, the global Anti-thrombin III Testing market size will reach US$ million by 2031.

Antithrombin (AT, Antithrombin III, ATIII) is a small glycoprotein produced by the liver that inactivates several enzymes of the coagulation system.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

LPI (LP Information)' newest research report, the “Anti-thrombin III Testing Industry Forecast” looks at past sales and reviews total world Anti-thrombin III Testing sales in 2024, providing a comprehensive analysis by region and market sector of projected Anti-thrombin III Testing sales for 2025 through 2031. With Anti-thrombin III Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anti-thrombin III Testing industry.

This Insight Report provides a comprehensive analysis of the global Anti-thrombin III Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Anti-thrombin III Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Anti-thrombin III Testing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anti-thrombin III Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anti-thrombin III Testing.

This report presents a comprehensive overview, market shares, and growth opportunities of Anti-thrombin III Testing market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Diagnosis of antithrombin deficiency
• Activity assays
• Immunological assays

Segmentation by Application:

• Hospital
• Research institute
• Clinic
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Abbott Laboratories
• Danaher Corp.
• F. Hoffmann-La Roche Ltd.
• Siemens Healthcare GmbH
• Thermo Fisher Scientific Inc.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Anti-thrombin III Testing Market Size (2020-2031)
  2.1.2 Anti-thrombin III Testing Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Anti-thrombin III Testing by Country/Region (2020, 2024 & 2031)
2.2 Anti-thrombin III Testing Segment by Type
  2.2.1 Diagnosis of antithrombin deficiency
  2.2.2 Activity assays
  2.2.3 Immunological assays
2.3 Anti-thrombin III Testing Market Size by Type
  2.3.1 Anti-thrombin III Testing Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Anti-thrombin III Testing Market Size Market Share by Type (2020-2025)
2.4 Anti-thrombin III Testing Segment by Application
  2.4.1 Hospital
  2.4.2 Research institute
  2.4.3 Clinic
  2.4.4 Other
2.5 Anti-thrombin III Testing Market Size by Application
  2.5.1 Anti-thrombin III Testing Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Anti-thrombin III Testing Market Size Market Share by Application (2020-2025)

3 ANTI-THROMBIN III TESTING MARKET SIZE BY PLAYER

3.1 Anti-thrombin III Testing Market Size Market Share by Player
  3.1.1 Global Anti-thrombin III Testing Revenue by Player (2020-2025)
  3.1.2 Global Anti-thrombin III Testing Revenue Market Share by Player (2020-2025)
3.2 Global Anti-thrombin III Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 ANTI-THROMBIN III TESTING BY REGION

4.1 Anti-thrombin III Testing Market Size by Region (2020-2025)
4.2 Global Anti-thrombin III Testing Annual Revenue by Country/Region (2020-2025)
4.3 Americas Anti-thrombin III Testing Market Size Growth (2020-2025)
4.4 APAC Anti-thrombin III Testing Market Size Growth (2020-2025)
4.5 Europe Anti-thrombin III Testing Market Size Growth (2020-2025)
4.6 Middle East & Africa Anti-thrombin III Testing Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Anti-thrombin III Testing Market Size by Country (2020-2025)
5.2 Americas Anti-thrombin III Testing Market Size by Type (2020-2025)
5.3 Americas Anti-thrombin III Testing Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Anti-thrombin III Testing Market Size by Region (2020-2025)
6.2 APAC Anti-thrombin III Testing Market Size by Type (2020-2025)
6.3 APAC Anti-thrombin III Testing Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Anti-thrombin III Testing Market Size by Country (2020-2025)
7.2 Europe Anti-thrombin III Testing Market Size by Type (2020-2025)
7.3 Europe Anti-thrombin III Testing Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Anti-thrombin III Testing by Region (2020-2025)
8.2 Middle East & Africa Anti-thrombin III Testing Market Size by Type (2020-2025)
8.3 Middle East & Africa Anti-thrombin III Testing Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL ANTI-THROMBIN III TESTING MARKET FORECAST

10.1 Global Anti-thrombin III Testing Forecast by Region (2026-2031)
  10.1.1 Global Anti-thrombin III Testing Forecast by Region (2026-2031)
  10.1.2 Americas Anti-thrombin III Testing Forecast
  10.1.3 APAC Anti-thrombin III Testing Forecast
  10.1.4 Europe Anti-thrombin III Testing Forecast
  10.1.5 Middle East & Africa Anti-thrombin III Testing Forecast
10.2 Americas Anti-thrombin III Testing Forecast by Country (2026-2031)
  10.2.1 United States Market Anti-thrombin III Testing Forecast
  10.2.2 Canada Market Anti-thrombin III Testing Forecast
  10.2.3 Mexico Market Anti-thrombin III Testing Forecast
  10.2.4 Brazil Market Anti-thrombin III Testing Forecast
10.3 APAC Anti-thrombin III Testing Forecast by Region (2026-2031)
  10.3.1 China Anti-thrombin III Testing Market Forecast
  10.3.2 Japan Market Anti-thrombin III Testing Forecast
  10.3.3 Korea Market Anti-thrombin III Testing Forecast
  10.3.4 Southeast Asia Market Anti-thrombin III Testing Forecast
  10.3.5 India Market Anti-thrombin III Testing Forecast
  10.3.6 Australia Market Anti-thrombin III Testing Forecast
10.4 Europe Anti-thrombin III Testing Forecast by Country (2026-2031)
  10.4.1 Germany Market Anti-thrombin III Testing Forecast
  10.4.2 France Market Anti-thrombin III Testing Forecast
  10.4.3 UK Market Anti-thrombin III Testing Forecast
  10.4.4 Italy Market Anti-thrombin III Testing Forecast
  10.4.5 Russia Market Anti-thrombin III Testing Forecast
10.5 Middle East & Africa Anti-thrombin III Testing Forecast by Region (2026-2031)
  10.5.1 Egypt Market Anti-thrombin III Testing Forecast
  10.5.2 South Africa Market Anti-thrombin III Testing Forecast
  10.5.3 Israel Market Anti-thrombin III Testing Forecast
  10.5.4 Turkey Market Anti-thrombin III Testing Forecast
10.6 Global Anti-thrombin III Testing Forecast by Type (2026-2031)
10.7 Global Anti-thrombin III Testing Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Anti-thrombin III Testing Forecast

11 KEY PLAYERS ANALYSIS

11.1 Abbott Laboratories
  11.1.1 Abbott Laboratories Company Information
  11.1.2 Abbott Laboratories Anti-thrombin III Testing Product Offered
  11.1.3 Abbott Laboratories Anti-thrombin III Testing Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Abbott Laboratories Main Business Overview
  11.1.5 Abbott Laboratories Latest Developments
11.2 Danaher Corp.
  11.2.1 Danaher Corp. Company Information
  11.2.2 Danaher Corp. Anti-thrombin III Testing Product Offered
  11.2.3 Danaher Corp. Anti-thrombin III Testing Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Danaher Corp. Main Business Overview
  11.2.5 Danaher Corp. Latest Developments
11.3 F. Hoffmann-La Roche Ltd.
  11.3.1 F. Hoffmann-La Roche Ltd. Company Information
  11.3.2 F. Hoffmann-La Roche Ltd. Anti-thrombin III Testing Product Offered
  11.3.3 F. Hoffmann-La Roche Ltd. Anti-thrombin III Testing Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 F. Hoffmann-La Roche Ltd. Main Business Overview
  11.3.5 F. Hoffmann-La Roche Ltd. Latest Developments
11.4 Siemens Healthcare GmbH
  11.4.1 Siemens Healthcare GmbH Company Information
  11.4.2 Siemens Healthcare GmbH Anti-thrombin III Testing Product Offered
  11.4.3 Siemens Healthcare GmbH Anti-thrombin III Testing Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Siemens Healthcare GmbH Main Business Overview
  11.4.5 Siemens Healthcare GmbH Latest Developments
11.5 Thermo Fisher Scientific Inc.
  11.5.1 Thermo Fisher Scientific Inc. Company Information
  11.5.2 Thermo Fisher Scientific Inc. Anti-thrombin III Testing Product Offered
  11.5.3 Thermo Fisher Scientific Inc. Anti-thrombin III Testing Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Thermo Fisher Scientific Inc. Main Business Overview
  11.5.5 Thermo Fisher Scientific Inc. Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Anti-thrombin III Testing Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Anti-thrombin III Testing Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Diagnosis of antithrombin deficiency
Table 4. Major Players of Activity assays
Table 5. Major Players of Immunological assays
Table 6. Anti-thrombin III Testing Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global Anti-thrombin III Testing Market Size by Type (2020-2025) & ($ millions)
Table 8. Global Anti-thrombin III Testing Market Size Market Share by Type (2020-2025)
Table 9. Anti-thrombin III Testing Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Anti-thrombin III Testing Market Size by Application (2020-2025) & ($ millions)
Table 11. Global Anti-thrombin III Testing Market Size Market Share by Application (2020-2025)
Table 12. Global Anti-thrombin III Testing Revenue by Player (2020-2025) & ($ millions)
Table 13. Global Anti-thrombin III Testing Revenue Market Share by Player (2020-2025)
Table 14. Anti-thrombin III Testing Key Players Head office and Products Offered
Table 15. Anti-thrombin III Testing Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Anti-thrombin III Testing Market Size by Region (2020-2025) & ($ millions)
Table 19. Global Anti-thrombin III Testing Market Size Market Share by Region (2020-2025)
Table 20. Global Anti-thrombin III Testing Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global Anti-thrombin III Testing Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas Anti-thrombin III Testing Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas Anti-thrombin III Testing Market Size Market Share by Country (2020-2025)
Table 24. Americas Anti-thrombin III Testing Market Size by Type (2020-2025) & ($ millions)
Table 25. Americas Anti-thrombin III Testing Market Size Market Share by Type (2020-2025)
Table 26. Americas Anti-thrombin III Testing Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas Anti-thrombin III Testing Market Size Market Share by Application (2020-2025)
Table 28. APAC Anti-thrombin III Testing Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC Anti-thrombin III Testing Market Size Market Share by Region (2020-2025)
Table 30. APAC Anti-thrombin III Testing Market Size by Type (2020-2025) & ($ millions)
Table 31. APAC Anti-thrombin III Testing Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe Anti-thrombin III Testing Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe Anti-thrombin III Testing Market Size Market Share by Country (2020-2025)
Table 34. Europe Anti-thrombin III Testing Market Size by Type (2020-2025) & ($ millions)
Table 35. Europe Anti-thrombin III Testing Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa Anti-thrombin III Testing Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa Anti-thrombin III Testing Market Size by Type (2020-2025) & ($ millions)
Table 38. Middle East & Africa Anti-thrombin III Testing Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Anti-thrombin III Testing
Table 40. Key Market Challenges & Risks of Anti-thrombin III Testing
Table 41. Key Industry Trends of Anti-thrombin III Testing
Table 42. Global Anti-thrombin III Testing Market Size Forecast by Region (2026-2031) & ($ millions)
Table 43. Global Anti-thrombin III Testing Market Size Market Share Forecast by Region (2026-2031)
Table 44. Global Anti-thrombin III Testing Market Size Forecast by Type (2026-2031) & ($ millions)
Table 45. Global Anti-thrombin III Testing Market Size Forecast by Application (2026-2031) & ($ millions)
Table 46. Abbott Laboratories Details, Company Type, Anti-thrombin III Testing Area Served and Its Competitors
Table 47. Abbott Laboratories Anti-thrombin III Testing Product Offered
Table 48. Abbott Laboratories Anti-thrombin III Testing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. Abbott Laboratories Main Business
Table 50. Abbott Laboratories Latest Developments
Table 51. Danaher Corp. Details, Company Type, Anti-thrombin III Testing Area Served and Its Competitors
Table 52. Danaher Corp. Anti-thrombin III Testing Product Offered
Table 53. Danaher Corp. Anti-thrombin III Testing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. Danaher Corp. Main Business
Table 55. Danaher Corp. Latest Developments
Table 56. F. Hoffmann-La Roche Ltd. Details, Company Type, Anti-thrombin III Testing Area Served and Its Competitors
Table 57. F. Hoffmann-La Roche Ltd. Anti-thrombin III Testing Product Offered
Table 58. F. Hoffmann-La Roche Ltd. Anti-thrombin III Testing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. F. Hoffmann-La Roche Ltd. Main Business
Table 60. F. Hoffmann-La Roche Ltd. Latest Developments
Table 61. Siemens Healthcare GmbH Details, Company Type, Anti-thrombin III Testing Area Served and Its Competitors
Table 62. Siemens Healthcare GmbH Anti-thrombin III Testing Product Offered
Table 63. Siemens Healthcare GmbH Anti-thrombin III Testing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. Siemens Healthcare GmbH Main Business
Table 65. Siemens Healthcare GmbH Latest Developments
Table 66. Thermo Fisher Scientific Inc. Details, Company Type, Anti-thrombin III Testing Area Served and Its Competitors
Table 67. Thermo Fisher Scientific Inc. Anti-thrombin III Testing Product Offered
Table 68. Thermo Fisher Scientific Inc. Anti-thrombin III Testing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. Thermo Fisher Scientific Inc. Main Business
Table 70. Thermo Fisher Scientific Inc. Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Anti-thrombin III Testing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Anti-thrombin III Testing Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Anti-thrombin III Testing Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Anti-thrombin III Testing Sales Market Share by Country/Region (2024)
Figure 8. Anti-thrombin III Testing Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Anti-thrombin III Testing Market Size Market Share by Type in 2024
Figure 10. Anti-thrombin III Testing in Hospital
Figure 11. Global Anti-thrombin III Testing Market: Hospital (2020-2025) & ($ millions)
Figure 12. Anti-thrombin III Testing in Research institute
Figure 13. Global Anti-thrombin III Testing Market: Research institute (2020-2025) & ($ millions)
Figure 14. Anti-thrombin III Testing in Clinic
Figure 15. Global Anti-thrombin III Testing Market: Clinic (2020-2025) & ($ millions)
Figure 16. Anti-thrombin III Testing in Other
Figure 17. Global Anti-thrombin III Testing Market: Other (2020-2025) & ($ millions)
Figure 18. Global Anti-thrombin III Testing Market Size Market Share by Application in 2024
Figure 19. Global Anti-thrombin III Testing Revenue Market Share by Player in 2024
Figure 20. Global Anti-thrombin III Testing Market Size Market Share by Region (2020-2025)
Figure 21. Americas Anti-thrombin III Testing Market Size 2020-2025 ($ millions)
Figure 22. APAC Anti-thrombin III Testing Market Size 2020-2025 ($ millions)
Figure 23. Europe Anti-thrombin III Testing Market Size 2020-2025 ($ millions)
Figure 24. Middle East & Africa Anti-thrombin III Testing Market Size 2020-2025 ($ millions)
Figure 25. Americas Anti-thrombin III Testing Value Market Share by Country in 2024
Figure 26. United States Anti-thrombin III Testing Market Size Growth 2020-2025 ($ millions)
Figure 27. Canada Anti-thrombin III Testing Market Size Growth 2020-2025 ($ millions)
Figure 28. Mexico Anti-thrombin III Testing Market Size Growth 2020-2025 ($ millions)
Figure 29. Brazil Anti-thrombin III Testing Market Size Growth 2020-2025 ($ millions)
Figure 30. APAC Anti-thrombin III Testing Market Size Market Share by Region in 2024
Figure 31. APAC Anti-thrombin III Testing Market Size Market Share by Type (2020-2025)
Figure 32. APAC Anti-thrombin III Testing Market Size Market Share by Application (2020-2025)
Figure 33. China Anti-thrombin III Testing Market Size Growth 2020-2025 ($ millions)
Figure 34. Japan Anti-thrombin III Testing Market Size Growth 2020-2025 ($ millions)
Figure 35. South Korea Anti-thrombin III Testing Market Size Growth 2020-2025 ($ millions)
Figure 36. Southeast Asia Anti-thrombin III Testing Market Size Growth 2020-2025 ($ millions)
Figure 37. India Anti-thrombin III Testing Market Size Growth 2020-2025 ($ millions)
Figure 38. Australia Anti-thrombin III Testing Market Size Growth 2020-2025 ($ millions)
Figure 39. Europe Anti-thrombin III Testing Market Size Market Share by Country in 2024
Figure 40. Europe Anti-thrombin III Testing Market Size Market Share by Type (2020-2025)
Figure 41. Europe Anti-thrombin III Testing Market Size Market Share by Application (2020-2025)
Figure 42. Germany Anti-thrombin III Testing Market Size Growth 2020-2025 ($ millions)
Figure 43. France Anti-thrombin III Testing Market Size Growth 2020-2025 ($ millions)
Figure 44. UK Anti-thrombin III Testing Market Size Growth 2020-2025 ($ millions)
Figure 45. Italy Anti-thrombin III Testing Market Size Growth 2020-2025 ($ millions)
Figure 46. Russia Anti-thrombin III Testing Market Size Growth 2020-2025 ($ millions)
Figure 47. Middle East & Africa Anti-thrombin III Testing Market Size Market Share by Region (2020-2025)
Figure 48. Middle East & Africa Anti-thrombin III Testing Market Size Market Share by Type (2020-2025)
Figure 49. Middle East & Africa Anti-thrombin III Testing Market Size Market Share by Application (2020-2025)
Figure 50. Egypt Anti-thrombin III Testing Market Size Growth 2020-2025 ($ millions)
Figure 51. South Africa Anti-thrombin III Testing Market Size Growth 2020-2025 ($ millions)
Figure 52. Israel Anti-thrombin III Testing Market Size Growth 2020-2025 ($ millions)
Figure 53. Turkey Anti-thrombin III Testing Market Size Growth 2020-2025 ($ millions)
Figure 54. GCC Countries Anti-thrombin III Testing Market Size Growth 2020-2025 ($ millions)
Figure 55. Americas Anti-thrombin III Testing Market Size 2026-2031 ($ millions)
Figure 56. APAC Anti-thrombin III Testing Market Size 2026-2031 ($ millions)
Figure 57. Europe Anti-thrombin III Testing Market Size 2026-2031 ($ millions)
Figure 58. Middle East & Africa Anti-thrombin III Testing Market Size 2026-2031 ($ millions)
Figure 59. United States Anti-thrombin III Testing Market Size 2026-2031 ($ millions)
Figure 60. Canada Anti-thrombin III Testing Market Size 2026-2031 ($ millions)
Figure 61. Mexico Anti-thrombin III Testing Market Size 2026-2031 ($ millions)
Figure 62. Brazil Anti-thrombin III Testing Market Size 2026-2031 ($ millions)
Figure 63. China Anti-thrombin III Testing Market Size 2026-2031 ($ millions)
Figure 64. Japan Anti-thrombin III Testing Market Size 2026-2031 ($ millions)
Figure 65. Korea Anti-thrombin III Testing Market Size 2026-2031 ($ millions)
Figure 66. Southeast Asia Anti-thrombin III Testing Market Size 2026-2031 ($ millions)
Figure 67. India Anti-thrombin III Testing Market Size 2026-2031 ($ millions)
Figure 68. Australia Anti-thrombin III Testing Market Size 2026-2031 ($ millions)
Figure 69. Germany Anti-thrombin III Testing Market Size 2026-2031 ($ millions)
Figure 70. France Anti-thrombin III Testing Market Size 2026-2031 ($ millions)
Figure 71. UK Anti-thrombin III Testing Market Size 2026-2031 ($ millions)
Figure 72. Italy Anti-thrombin III Testing Market Size 2026-2031 ($ millions)
Figure 73. Russia Anti-thrombin III Testing Market Size 2026-2031 ($ millions)
Figure 74. Egypt Anti-thrombin III Testing Market Size 2026-2031 ($ millions)
Figure 75. South Africa Anti-thrombin III Testing Market Size 2026-2031 ($ millions)
Figure 76. Israel Anti-thrombin III Testing Market Size 2026-2031 ($ millions)
Figure 77. Turkey Anti-thrombin III Testing Market Size 2026-2031 ($ millions)
Figure 78. Global Anti-thrombin III Testing Market Size Market Share Forecast by Type (2026-2031)
Figure 79. Global Anti-thrombin III Testing Market Size Market Share Forecast by Application (2026-2031)
Figure 80. GCC Countries Anti-thrombin III Testing Market Size 2026-2031 ($ millions)